Incyte Corp banner

Intrinsic Value

The intrinsic value of Incyte Corp (0J9P) under the Base Case is USD per share. Compared with the current market price of 121.74 USD, the stock appears .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

0J9P Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when 0J9P is below its intrinsic value
Today Hidden ·
0J9P Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to 0J9P

Fundamental Analysis

What Incyte Does

Biotechnology Health Care

Incyte Corp is a biopharmaceutical company that discovers, develops, and sells prescription medicines, mainly for cancer and immune-related diseases. Its best-known products include treatments used by specialists in oncology and dermatology, where doctors prescribe the drugs to patients with conditions such as blood cancers, graft-versus-host disease, and inflammatory skin disorders.

Headquarters
United States of America US
Employees
2 844
IPO date
Dec 6, 1993
Read the full company overview
View Company Overview

Incyte has no economic moat

No Moat Narrow Wide

Incyte’s medicines face other treatments that doctors and patients can choose instead, and customers generally are not locked into using the company’s products. Patents can hold off copies for a time, but they do not protect the business indefinitely as other drugs compete for the same patients.

Read the full moat analysis
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q3 2026 · October 29, 2026

Incyte raised its full-year net-sales outlook as product growth broadened, while advancing late-stage programs and refocusing CDK2 development on maintenance.

Open the earnings call
EPS
−$3.79
Expected
−$4.27
Surprise
+11.2%
Stock, day of the call
−0.1%
View Earnings Call

Incyte insiders are selling about as much as last year

Insider trading · Last trade on Nov 3, 2026

Sold $24m 7 insiders
Bought $0 Nobody bought
Trades by date
Open insider trading

Past 12 months

Continue 0J9P Research

Decided on Incyte? Get an email when 0J9P reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one 0J9P stock?

The intrinsic value for Incyte Corp (0J9P) under the Base Case is USD.

Is 0J9P stock undervalued or overvalued?

Compared with the current market price of 121.74 USD, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top